Nitheesha Ganta MD, FACC, and Aditi Nayak, MD, MS, FACC, have joined Baylor Scott & White Advanced Heart Failure Clinic – Dallas. Both physicians are fellowship-trained in advanced heart failure and transplant cardiology from two of the nation’s most prestigious institutions. Within the field of advanced heart failure, Dr. Ganta has special interests in cardiogenic ..read more

Heart failure is a universal problem. Worldwide, the prevalence of heart failure is 1-3 percent in the general adult population. While traditional data showed heart failure with reduced ejection fraction (HFrEF) had slightly higher incidence than heart failure with preserved ejection fraction (HFpEF), this relationship has flipped recently. Two factors account for this decrease. The ..read more

Sex (biological factors) and gender (socio-culturally constructed norms) affect almost every aspect of cardiovascular disease. For women with heart failure, this confluence of sex and gender results in unique and significant differences from men with the same condition, from clinical presentation and management to clinical outcomes. In the context of heart failure, generally speaking, the ..read more

The American Transplant Congress (ATC) is the annual international meeting for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS). Heart transplant physician researchers from the Center for Advanced Heart and Lung Disease at Baylor University Medical Center at Dallas (Baylor Dallas) played a prominent role in ATC 2024, which ..read more

The Aurora Extravascular ICD system is designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest, while avoiding certain risks of traditional, transvenous ICDs because its lead is placed outside the heart and veins, under the breastbone using a minimally invasive approach. On Nov. 14, 2023, 40-year-old James Norman became the ..read more

For more than three years, the cardiology team at Baylor Scott & White Heart and Vascular Hospital – Fort Worth has been an active enrollment site for the Amplatzer Amulet LAAO vs. NOAC clinical trial (CATALYST). To refer a patient for enrollment in the CATALYST trial, contact 817.922.1398 or Kristina.Perez@BSWHealth.org. “The objective of the trial ..read more

Transthyretin, or ATTR, amyloidosis is a rare disease that, if left untreated, can be devasting and fatal to the patient. Fortunately, in the past decade, there have been advancements in specialized therapies targeting this disease that can improve both quality of life and survival. The Advanced Heart and Lung Disease Center at Baylor Scott & ..read more

The incidence of mitral valve disease (MVD) is growing as the overall population ages. Mitral valve disease describes the condition when the mitral valve doesn’t work properly, allowing blood to flow back into the left atrium. When this occurs, the heart doesn’t pump enough blood out of the left ventricle to supply the body with ..read more

Baylor Scott & White was the first hospital system in North Texas to successfully implant Barostim™ Baroreflex Activation Therapy. This new FDA-approved device uses neuromodulation—the power of the brain and nervous system to improve the symptoms of patients with advanced systolic heart failure. Eligible patients are reviewed by the patient’s advanced heart failure cardiologist and ..read more

J. Sebastian Danobeitia, MD, PhD, has joined the medical staff at Baylor Annette C. and Harold C. Simmons Transplant Institute. An abdominal transplant surgeon specializing in liver, kidney, pancreas and islet transplantation, Dr. Danobeitia is part of the transplant team at Baylor University Medical Center at Dallas, part of Baylor Scott & White Health. “The ..read more